Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease

Drugs activating group III metabotropic glutamate receptors (mGluRs) represent therapeutic alternatives to l-DOPA (l-3,4-dihydroxyphenylalanine) for the treatment of Parkinson's disease (PD). Their presynaptic location at GABAergic and glutamatergic synapses within basal ganglia nuclei provide...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurosci
Egile Nagusiak: Lopez, Sebastien, Turle-Lorenzo, Nathalie, Acher, Francine, De Leonibus, Elvira, Mele, Andrea, Amalric, Marianne
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Neuroscience 2007
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6672706/
https://ncbi.nlm.nih.gov/pubmed/17581957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0299-07.2007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak